期刊文献+

钆塞酸二钠肝胆期成像在肝癌检出与定性方面的价值 被引量:8

下载PDF
导出
摘要 流行病学研究表明,肝癌的发生与酒精性肝硬化、乙型肝炎、丙型肝炎等慢性肝病密切相关,原发性肝癌早期症状通常不典型,但其恶性程度高,侵袭性强,因此肝癌的早期诊断及早期治疗显得尤为重要。钆塞酸二钠(普美显,Gd-EOBDTPA)是一类新型肝脏特异性对比剂,
出处 《肝脏》 2017年第10期959-961,共3页 Chinese Hepatology
  • 相关文献

参考文献4

二级参考文献47

  • 1程伟中,曾蒙苏.新型多功能磁共振对比剂Gd-EOB-DTPA在肝胆系统病变中的应用[J].临床放射学杂志,2005,24(12):1107-1110. 被引量:15
  • 2Lim KO, Stark DD, Leese PT,et al. Hepatobiliary MRI: first human experience with MnDPDP. Radiology, 1991, 178:79.
  • 3Witzleben CL, Pitlick P, Bergmeyer J,et al. Acute manganese overload: a new experiental model of intrahepatic cholestasis. Am J Pathol, 1968, 55:409.
  • 4Hamm B, Kirchin M, Pirovano G,et al. Clinical utility and safety of multihance in MRI of liver cancer: results of multicenter studies in europe and the USA. J Comput Assist Tomogr, 1999, 53.
  • 5Schuhmann-Giampieri G, Schmitt-Willich H, Press WR,et al. Preclinical evaluation of Gd-EOB-DTPA as a contrast agent in MR imaging of the hepatobiliary system. Radiology, 1992, 183:56.
  • 6Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H,et al. A new lipophilic gadoliniumchelate as a tissue-specific contrast medium for MR imaging. Magn Reson Med, 1991, 22:233.
  • 7Hamm B, Staks T, Muhler A,et al. Phase Ⅰ chinical evaluation of Gd-EOB-DTPA as a hepatobiliary MR contrast agent: Safety, pharmacokinetics, and MR imaging. Radiology, 1995, 195:785.
  • 8Reimer P, Rummeny EJ, Shamsi K,et al. Phase Ⅱ clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence. Radiology, 1996, 199:177.
  • 9Semelka RC, Helmberger TK. Contrast agents for MR imaging of the liver. Radiology, 2001, 218:27.
  • 10Moseley RH. Mechanisms of bile formation and cholestasis: clinical significance of recent experimental work. Am J Gastroenterol, 1986, 81:731.

共引文献82

同被引文献58

引证文献8

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部